Oculomucocutaneous syndrome

Oculomucocutaneous syndrome is characterized by and by scarring, fibrosis, metaplasia, and shrinkage of the conjunctiva. It is a drug side effect observed in practolol and eperisone. It is speculated that antibodies against drug metabolites cause the syndrome.